CETP Inhibition: What We've Learned and What's Next: Quickfire Countdown episode artwork

EPISODE · Jun 25, 2026 · 21 MIN

CETP Inhibition: What We've Learned and What's Next: Quickfire Countdown

from Keeping Current CME

Why did early cholesteryl ester transfer protein (CETP) inhibitors fail despite raising high-density lipoprotein cholesterol (HDL-C), and how does contemporary evidence change the therapeutic outlook? Credit available for this activity expires: 6/24/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/cetp-inhibition-what-weve-learned-and-whats-next-quickfire-2026a1000kip?ecd=bdc_podcast_libsyn_mscpedu

Episode metadata supplied by the publisher feed · Published Jun 25, 2026

Embed this episode

NOW PLAYING

CETP Inhibition: What We've Learned and What's Next: Quickfire Countdown

0:00 21:31

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Keeping Current CME?

This episode is 21 minutes long.

When was this Keeping Current CME episode published?

This episode was published on June 25, 2026.

Can I download this Keeping Current CME episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!